Raushan Kurmasheva
0000-0003-3212-2363
4 papers found
Refreshing results…
Evaluation of the pan‐class I phosphoinositide 3‐kinase (PI3K) inhibitor copanlisib in the Pediatric Preclinical Testing Consortium in vivo models of osteosarcoma
Trastuzumab Deruxtecan, Antibody–Drug Conjugate Targeting HER2, Is Effective in Pediatric Malignancies: A Report by the Pediatric Preclinical Testing Consortium
Comprehensive surfaceome profiling to identify and validate novel cell-surface targets in osteosarcoma
The B7-H3-targeting antibody-drug conjugate m276-SL-PBD is potently effective against pediatric cancer preclinical solid tumor models
Missing publications? Search for publications with a matching author name.